Elena Sancho

7PUBLICATIONS
72CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 07, 2025
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages.

Ana Henriques, Maria Salvany-Celades, Paula Nieto

|Oct 23, 2025
A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer.

Alessia Centonze, Adrià-Jaume Roura, Meritxell Novillo-Font

|Sep 02, 2024
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities.

Mariangela Russo, Mengnuo Chen, Elisa Mariella

|Nov 09, 2022
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.

Adrià Cañellas-Socias, Carme Cortina, Xavier Hernando-Momblona

|Jun 30, 2022
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.

Adrián Álvarez-Varela, Laura Novellasdemunt, Francisco M Barriga

|Apr 26, 2022
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors.

Bram Herpers, Berina Eppink, Mark I James

Pageof 2

Frequent Collaborators

7 joint publications

Eduard Batlle

5 joint publications

Camille Stephan-Otto Attolini

4 joint publications

Daniele V F Tauriello

3 joint publications

Lidia Mateo